AAM Calls For FTC Scrutiny Of Pharmacy Benefit Manager Practices
PBMs Often Fail To Encourage Generic And Biosimilar Use
Pharmacy benefit managers often fail to encourage the use of generic and biosimilar medications and in fact undermine patient access to these more affordable drugs, the Association for Accessible Medicines has told the US Federal Trade Commission.
